Abstract 3270: the XernaTM TME Panel Potentially Predicts Response to a Combination of the TLR9 Agonist Vidutolimod and PD-1 Inhibitor Pembrolizumab in Metastatic Melanomas with Prior Anti-Pd-1 Treatment
Cancer Research（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要